Try
STERIS plc
STEUnited States
56 filed reports · 604 financial concepts · 2 earnings calls · 0 media appearances
Filed reports
56 reports · Mar 2019 to Jun 2026Each report counts once it has at least one extracted financial fact. Also extracted from these reports: 286 guidance figures.
| Report type | Reports | Facts | Periods |
|---|---|---|---|
| Current · 8-KSEC EDGAR | 26 | 244 | Mar 2019 to Jun 2026 |
| Quarterly · 10-QSEC EDGAR | 22 | 5,577 | Jun 2019 to Jun 2026 |
| Annual · 10-KSEC EDGAR | 8 | 5,911 | Mar 2019 to Mar 2026 |
Documents
| Period | Type | Period end | Published | Facts | Source |
|---|---|---|---|---|---|
| FY2027 Q1 | 10-Q | Jun 30, 2026 | Aug 7, 2026 | 475 | Open |
| FY2027 Q1 | 8-K | Jun 30, 2026 | Aug 5, 2026 | 12 | Open |
| FY2026 | 10-K | Mar 31, 2026 | May 29, 2026 | 1,251 | Open |
| FY2026 Q4 | 8-K | Mar 31, 2026 | May 11, 2026 | 10 | Open |
| FY2026 Q3 | 10-Q | Dec 31, 2025 | Feb 6, 2026 | 364 | Open |
| FY2026 Q3 | 8-K | Dec 31, 2025 | Feb 4, 2026 | 10 | Open |
| FY2026 Q2 | 10-Q | Sep 30, 2025 | Nov 6, 2025 | 353 | Open |
| FY2026 Q2 | 8-K | Sep 30, 2025 | Nov 5, 2025 | 10 | Open |
| FY2026 Q1 | 10-Q | Jun 30, 2025 | Aug 7, 2025 | 253 | Open |
| FY2026 Q1 | 8-K | Jun 30, 2025 | Aug 6, 2025 | 8 | Open |
| FY2025 | 10-K | Mar 31, 2025 | May 29, 2025 | 660 | Open |
| FY2025 Q4 | 8-K | Mar 31, 2025 | May 14, 2025 | 8 | Open |
Financial data
604 concepts · 11,732 factsEach concept is one reported line item or metric. The count is how many values of it are held, across the periods shown.
Financial561 concepts · 10,104 facts · Mar 2017 to Aug 2026
- Gross profit (US GAAP)47 · Mar 2017 to Jun 2026
- Net income loss47 · Mar 2017 to Jun 2026
- Revenue47 · Mar 2017 to Jun 2026
- Restructuring charges46 · Mar 2017 to Mar 2026
- Accumulated other comprehensive income loss net of tax45 · Mar 2017 to Jun 2026
- Cash and cash equivalents at carrying value45 · Mar 2017 to Jun 2026
- Stockholders equity including portion attributable to noncontrolling interest45 · Mar 2017 to Jun 2026
- Amortization of acquired intangible assets43 · Mar 2017 to Jun 2026
- Amortization of inventory and property step-up to fair value43 · Mar 2017 to Jun 2026
- Comprehensive income net of tax43 · Mar 2017 to Jun 2026
- Deferred income tax expense benefit43 · Mar 2017 to Jun 2026
- Depreciation depletion and amortization43 · Mar 2017 to Jun 2026
- Dividends common stock cash43 · Mar 2017 to Jun 2026
- Earnings per share basic43 · Mar 2017 to Mar 2026
- Earnings per share diluted43 · Mar 2017 to Mar 2026
- Income tax expense benefit43 · Mar 2017 to Jun 2026
- Increase decrease in accounts payable43 · Mar 2017 to Jun 2026
- Increase decrease in accounts receivable43 · Mar 2017 to Jun 2026
- Increase decrease in accrued liabilities43 · Mar 2017 to Jun 2026
- Increase decrease in inventories43 · Mar 2017 to Jun 2026
- Increase decrease in prepaid deferred expense and other assets43 · Mar 2017 to Jun 2026
- Net cash provided by used in financing activities43 · Mar 2017 to Jun 2026
- Net cash provided by used in investing activities43 · Mar 2017 to Jun 2026
- Net cash provided by used in operating activities43 · Mar 2017 to Jun 2026
Segment22 concepts · 1,001 facts · Mar 2017 to Jun 2026
- Revenue509 · Mar 2017 to Jun 2026
- Operating income loss192 · Mar 2017 to Dec 2025
- Cost of revenue (US GAAP)41 · Mar 2023 to Jun 2026
- Research and development expense41 · Mar 2023 to Jun 2026
- Selling general and administrative expense41 · Mar 2023 to Jun 2026
- Total Assets40 · Mar 2018 to Mar 2026
- Operating Segments38 · Mar 2023 to Jun 2026
- Restructuring charges19 · Mar 2019 to Jun 2020
- Depreciation depletion and amortization14 · Mar 2017 to Mar 2021
- Payments to acquire productive assets14 · Mar 2017 to Mar 2021
- Operating Income13 · Mar 2018 to Dec 2025
- Restructuring expense incurred since Plan inception7 · Mar 2020 to Mar 2021
- Depreciation & Amortization6 · Mar 2024 to Mar 2026
- Goodwill4 · Mar 2018 to Dec 2021
- Goodwill transfers4 · Mar 2018
- Cost of Revenue3 · Jun 2024 to Sep 2025
- Goodwill acquired during period3 · Mar 2018 to Mar 2020
- R&D Expense3 · Jun 2024 to Sep 2025
- Restructuring costs3 · Dec 2020
- SG&A Expense3 · Jun 2024 to Sep 2025
- Goodwill foreign currency translation gain loss2 · Mar 2019 to Mar 2020
- Goodwill impairment loss1 · Mar 2017
Guidance14 concepts · 244 facts · May 2019 to Aug 2026
- Capital Expenditures Guidance42 · May 2019 to Aug 2026
- Revenue Growth Guidance42 · May 2021 to Aug 2026
- EPS (Diluted) Guidance38 · May 2019 to Aug 2026
- Free Cash Flow Guidance32 · May 2021 to May 2026
- Effective Tax Rate Guidance20 · May 2021 to May 2026
- EPS (Diluted) Guidance (Adjusted (non-GAAP))18 · May 2019 to Aug 2026
- Free Cash Flow Guidance (Adjusted (non-GAAP))18 · May 2019 to Aug 2026
- Revenue Growth Guidance (Organic, constant currency)16 · May 2019 to Feb 2024
- Effective Tax Rate Guidance (Adjusted (non-GAAP))6 · May 2019 to May 2022
- Revenue Guidance4 · May 2021 to Aug 2021
- EPS (Diluted) Guidance (continuing operations; Adjusted (non-GAAP))2 · May 2024
- Revenue Growth Guidance (Constant currency)2 · Aug 2026
- Revenue Growth Guidance (continuing operations)2 · May 2024
- Revenue Growth Guidance (continuing operations; Organic, constant currency)2 · May 2024
Geography5 concepts · 195 facts · Mar 2017 to Jun 2026
- Revenue132 · Mar 2017 to Jun 2026
- Property, Plant & Equipment, Net58 · Mar 2018 to Jun 2026
- Goodwill impairment loss2 · Mar 2023
- Valuation allowance deferred tax asset change in amount2 · Mar 2024 to Mar 2025
- Business combination acquisition related costs1 · Mar 2022
Product2 concepts · 188 facts · Mar 2017 to Jun 2026
- Cost of goods and services sold (US GAAP)94 · Mar 2017 to Jun 2026
- Revenue94 · Mar 2017 to Jun 2026
Segments
1,384 factsFigures broken down by business line, region, product or another axis the company reports on.
Statement business segments25 members · 1,001 facts
- Life Science Member210 · Mar 2017 to Mar 2026
- Applied Sterilization Technologies185 · Mar 2017 to Jun 2026
- Healthcare148 · Mar 2019 to Jun 2026
- Healthcare Member91 · Jun 2019 to Dec 2024
- Healthcare Products Member66 · Mar 2017 to Mar 2020
- Operatingsegmentall55 · Mar 2017 to Dec 2025
- Life Science51 · Sep 2024 to Jun 2026
- Healthcare Specialty Services39 · Mar 2017 to Mar 2020
- Operatingsegmentcorpandother31 · Mar 2017 to Dec 2025
- Dental24 · Jun 2020 to Dec 2023
- Applied sterilization technologies22 · Mar 2018 to Mar 2026
- Healthcare Productsand Life Sciences10 · Mar 2017 to Mar 2021
- Operatingsegmentallexceptcorpandother10 · Mar 2017 to Mar 2021
- Healthcare productsand life sciences10 · Mar 2018 to Mar 2026
- Healthcare segment9 · Jun 2024 to Sep 2025
- Operatingsegmentall9 · Sep 2022 to Dec 2025
- Healthcareand life sciences8 · Mar 2020 to Dec 2021
- Operatingsegmentallexceptcorpandother8 · Mar 2018 to Mar 2021
- Goodwill Acquired Or Allocated Member3 · Mar 2018 to Mar 2020
- Dental3 · Jun 2021 to Dec 2021
- Healthcare specialty services3 · Mar 2018 to Mar 2020
- Foreign Currency Gain Loss2 · Mar 2019 to Mar 2020
- Foreign currency gain loss2 · Mar 2018 to Mar 2019
- Ast1 · Dec 2021
- Healthcare life sciences1 · Dec 2021
Statement geographical10 members · 195 facts
- US45 · Mar 2017 to Jun 2026
- IE42 · Mar 2018 to Jun 2026
- Otherforeignlocations41 · Mar 2017 to Mar 2026
- Ie19 · Mar 2018 to Jun 2026
- Us19 · Mar 2018 to Jun 2026
- Other foreign entities member16 · Mar 2018 to Mar 2026
- Non Us4 · Dec 2024 to Jun 2026
- Non us4 · Mar 2025 to Jun 2026
- GB3 · Mar 2017 to Mar 2019
- Other Locations2 · Mar 2024 to Mar 2025
Product or service2 members · 188 facts
- Product94 · Mar 2017 to Jun 2026
- Service94 · Mar 2017 to Jun 2026
Text from filings
Management commentary and risk factors, extracted from SEC filings only.
- Earnings-release commentary64 claims from 8 reports · Sep 2024 to Jun 2026
- Management discussion (MD&A) commentary220 claims from 8 reports · Sep 2024 to Jun 2026
- Risk-factor changes19 claims from 1 reports · Mar 2026
- Risk factors68 risks from 2 annual reports · 2025 to 2026
Earnings calls
2 calls · May 2026 to Aug 2026Transcripts with management claims and analyst questions, one per fiscal period.
- FY2027 Q1Aug 5, 2026
- FY2026 Q4May 11, 2026
Executive media
Podcasts, interviews and conference appearances by the company's executives, with their claims.
No media appearances for this company.
Reports are counted as filed reports with at least one served fact. Counts are read from the database (last read Oct 16, 2026) and refreshed every few hours.